Last updated:
Psilocybe Semilanceata
"Liberty Cap"
![[object Object]](https://d16q8n2b2c01ef.cloudfront.net/media/PsilocybeSemilanceata_new-800x450.webp)
Scientific Classification
About
Psilocybe semilanceata, commonly known as the Liberty Cap, is one of the most widely distributed and potent psilocybin mushrooms in the world. Recognizable by its distinct conical “nipple”-shaped cap, this species thrives in grassy fields, meadows, and pastures, especially those grazed by sheep or cattle. It is notable for its high psilocybin content, long history of use, and prevalence in Europe, North America, and New Zealand.
History
Liberty Caps have been used in ethnomycological practices for centuries. The first scientific documentation dates back to 1838 by Elias Magnus Fries, and it gained major psychedelic relevance when R. Gordon Wasson identified it as psychoactive in 1960s Europe.
It remains one of the most foraged wild psychedelic mushrooms, particularly in the UK, Ireland, and the Pacific Northwest. It’s revered both for its potency and deep, introspective psychedelic effects, often described as mystical or transcendental.
Overview
The mushroom has a slim, wavy stem (up to 10 cm) and a distinctive bell-shaped to conical cap, 0.5–2.5 cm wide, often with a protruding umbo (tip), giving it the appearance of a liberty cap. The cap color ranges from yellow-brown to olive and becomes hygrophanous (fades as it dries). It bruises blue when handled.
Psilocybe semilanceata is extremely potent for its size, typically producing vivid visuals, time distortion, emotional depth, and spiritual insight. It’s consumed fresh or dried, and users are advised to dose carefully due to the mushroom’s high psilocybin concentration relative to its size.
Physical Characteristics
Caps:
Conic to bell-shaped, acute papilla, hygrophanous, 0.5-2 cm wide, yellowish-brown to olive-brown when moist, pale ochre when dry
Gills:
Adnate to adnexed, initially pale, becoming purplish-black with age
Psychoactive Effects
Euphoric
Describing intense feelings of happiness or excitement
Perceptual
The change in the way things are perceived, including changes in time perception, spatial perception, and perception of one's own body.
Pharmacology
Helps With
Depression
Relieves symptoms of depression, improving mood and outlook
Anxiety
Helps to alleviate feelings of worry, fear, and unease
Addiction
Helps to overcome addiction and substance abuse
PTSD
Helps to alleviate symptoms of post-traumatic stress disorder
OCD
Helps to alleviate symptoms of obsessive-compulsive disorder
ADD ADHD
Helps to alleviate symptoms of attention deficit disorder and attention deficit hyperactivity disorder
Pain
Microdosing psilocybin has been shown to help with certain types of pain
Migraines
Research shows that psilocybin, the active compound in magic mushrooms, has potential therapeutic benefits for migraines. A small-scale study conducted by Yale School of Medicine found that a single dose of psilocybin reduced the likelihood of having a migraine attack in two weeks.
Possible Side Effects
Nausea
A feeling of discomfort in the stomach with an urge to vomit
Grow at Home
Start your cultivation journey with quality grow kits from verified vendors
Chemical Constituents
Medicinal Chemistry
Similar Species
![[object Object]](https://d16q8n2b2c01ef.cloudfront.net/media/PanaeolusFoenisecii_new-400x400.webp)
Species: Panaeolus foenisecii
Edibility: Psychoactive
Key Differences: P. foenisecii lacks the distinct papilla on the cap and has a more slender stem compared to P. semilanceata.
![[object Object]](https://d16q8n2b2c01ef.cloudfront.net/media/PanaeolusFoenisecii_new-400x400.webp)
Species: Panaeolus foenisecii
Edibility: Psychoactive
Mushroom Ratings
0.0
Based on 0 Reviews
5
★4
★3
★2
★1
★Share your thoughts
If you've consumed this mushroom, share your thoughts with our community
References
- Sekssaoui, M. (2024). Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?. .
- Ley, L. (2023). Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. .
- Bae, S. (2023). Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis. .
- Schindler, E. (2022 ). Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial. .
- Barrett, F. (2022). Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation. .
- Desai, S. (2022). Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users—A National Survey Study. .
- Rucker, J. (2021). Psilocybin: From Serendipity to Credibility?. .
- Schindler, E. (2021). Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin. .
- Raval, N. (2021). A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain. .
- Kuypers, K. (2019). Psychedelic medicine: The biology underlying the persisting psychedelic effects. .